Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Ed Overfield shares his personal battle with non-small cell lung cancer, a journey marked by the loss of his mother to the same disease and his own diagnosis…
This presentation delves into the pathophysiology of CML, highlighting its progression from the chronic phase through the accelerated phase to the blast phase.…
Rajdeep Mysore, MD discusses melanoma, the most dangerous type of skin cancer. Originating from melanocytes, the color-producing cells in the skin, melanomas often appear as black or brown…
This presentation delves into the pathophysiology of CML, highlighting its progression from the chronic phase through the accelerated phase to the blast phase.
Helen Rizos, PhD focuses on the clinical value of cell-free DNA in the management of melanoma. It highlights how circulating tumor DNA can be predictive and prognostic for…
This video shares the journey of how the pap smear, a crucial test for cervical cancer, became a routine part of healthcare for women. It highlights the diverse…
Most vaccines help the immune system learn to identify and fight off harmful viruses or bacteria before someone gets sick. But, scientists are also creating vaccines to treat…
Angela Belcher, PhD; Sangeeta Bhatia, MD, PhD; and Paula Hammond, PhD, from the Koch Institute at MIT, Cambridge, MA, present multi-dimensional approaches to early detection in ovarian cancer.…
Emma Rossi, MD, a gynecologic oncologist at Duke Health, discusses cervical cancer prevention and HPV. Dr Rossi explains that cervical cancer is the third most common gynecologic cancer…
